SE8100563L - 17alfa-acyloxi-5beta och 5alfa-kortikoider - Google Patents

17alfa-acyloxi-5beta och 5alfa-kortikoider

Info

Publication number
SE8100563L
SE8100563L SE8100563A SE8100563A SE8100563L SE 8100563 L SE8100563 L SE 8100563L SE 8100563 A SE8100563 A SE 8100563A SE 8100563 A SE8100563 A SE 8100563A SE 8100563 L SE8100563 L SE 8100563L
Authority
SE
Sweden
Prior art keywords
corticoides
acyloxi
5alfa
17alfa
5beta
Prior art date
Application number
SE8100563A
Other languages
Unknown language ( )
English (en)
Inventor
D E Ayer
C A Schlagel
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SE8100563L publication Critical patent/SE8100563L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8100563A 1980-01-31 1981-01-28 17alfa-acyloxi-5beta och 5alfa-kortikoider SE8100563L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/117,401 US4318853A (en) 1980-01-31 1980-01-31 9β,11β-Epoxy-5β-corticoids

Publications (1)

Publication Number Publication Date
SE8100563L true SE8100563L (sv) 1981-08-01

Family

ID=22372732

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8100563A SE8100563L (sv) 1980-01-31 1981-01-28 17alfa-acyloxi-5beta och 5alfa-kortikoider

Country Status (18)

Country Link
US (1) US4318853A (sv)
JP (1) JPS56122398A (sv)
KR (1) KR850001208B1 (sv)
AU (1) AU538883B2 (sv)
BE (1) BE887323A (sv)
CA (1) CA1155108A (sv)
CH (1) CH644614A5 (sv)
DE (1) DE3102397A1 (sv)
DK (1) DK39281A (sv)
ES (1) ES8300342A1 (sv)
FR (1) FR2475048A1 (sv)
GB (1) GB2070016B (sv)
GR (1) GR73511B (sv)
IT (1) IT1193576B (sv)
NL (1) NL8100467A (sv)
PH (2) PH16525A (sv)
SE (1) SE8100563L (sv)
ZA (1) ZA8118B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3243482A1 (de) * 1982-11-22 1984-05-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
WO1987002672A1 (en) * 1985-10-23 1987-05-07 The Upjohn Company Tetrahydro angiostatic steroids
NL8900507A (nl) * 1989-03-02 1990-10-01 Philips Nv Versterkerschakeling met verzadigingsdetectie.
CA2139549A1 (en) * 1994-01-28 1995-07-29 Kazumi Ogata Corticoid derivatives and pharmaceutical and cosmetic compositions
GB2302807A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Method and composition for treating atopic eczema
DE19737348C2 (de) 1997-08-27 2002-07-25 Dan-Gabriel Vulpescu Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
KR101591482B1 (ko) 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 ＮＦ-κＢ 의 비호르몬성 스테로이드 조절제
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
CN102225959B (zh) * 2011-04-29 2012-11-07 中国科学院上海有机化学研究所 一种16β-甲基-17α-羟基孕甾-3,20-二酮化合物及其合成方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2831874A (en) * 1954-04-20 1958-04-22 Gnrd Patent Holdings Ltd Improvements in the preparation of 17:21-diacyloxy-2:4-dibromo-3:11:20-triketoallopregnanes
US2854465A (en) * 1955-02-18 1958-09-30 Ciba Pharm Prod Inc Process for the manufacture of halogen-pregnanes and dehalogenation products thereof
DE1195748B (de) * 1961-06-24 1965-07-01 Vismara Francesco Spa Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
US3681410A (en) * 1970-08-07 1972-08-01 Syntex Corp Process for preparing 17{60 -hydroxy-20-keto and 17{60 ,21-dihydroxy-20-keto pregnanes and derivatives and intermediates thereof

Also Published As

Publication number Publication date
CA1155108A (en) 1983-10-11
FR2475048B1 (sv) 1984-11-16
GB2070016B (en) 1983-09-14
KR830005263A (ko) 1983-08-03
FR2475048A1 (fr) 1981-08-07
PH19579A (en) 1986-05-26
NL8100467A (nl) 1981-09-01
AU538883B2 (en) 1984-08-30
KR850001208B1 (ko) 1985-08-20
DE3102397A1 (de) 1981-12-24
CH644614A5 (de) 1984-08-15
GR73511B (sv) 1984-03-07
DK39281A (da) 1981-08-01
ZA8118B (en) 1982-01-27
IT8119360A0 (it) 1981-01-27
ES498938A0 (es) 1982-11-01
GB2070016A (en) 1981-09-03
JPS56122398A (en) 1981-09-25
BE887323A (fr) 1981-07-30
US4318853A (en) 1982-03-09
IT1193576B (it) 1988-07-08
ES8300342A1 (es) 1982-11-01
AU6651381A (en) 1981-08-06
PH16525A (en) 1983-11-10

Similar Documents

Publication Publication Date Title
DE3584203D1 (de) Hochfrequenzleistungsverstaerker mit bipolaren transistoren.
DE3686096D1 (de) Symmetrischer differenzverstaerker.
ES520522A0 (es) Perfeccionamientos en las valvulas magneticas con amplificador de potencia.
FI852272A0 (fi) Foerbaettringar i och angaoende gasmaskar.
SE8100563L (sv) 17alfa-acyloxi-5beta och 5alfa-kortikoider
FR2490896B1 (fr) Amplificateur d'echantillonnage lineaire a gain eleve
TR19630A (tr) Stabilize glukos isomerasi enzimi konsentrati ve imaline mahsus usul
IT8026096A0 (it) Amplificatore con controllo della corrente di incrocio.
DE3667230D1 (de) Verstaerkeranordnung.
FI854032A0 (fi) Mjukgoerande och antistatisk tvaettmedelskomposition i vaetskeform.
FI850607A0 (fi) Foerfarande foer avlaegsnande av loesta och i kolloidal form varande stormolekyliga organiska aemnen ur traefoeraedlingsindustrins avfallsvatten.
FR2421510B1 (fr) Amplificateur isolateur
DE3671685D1 (de) Verstaerkeranordnung.
SE416370B (sv) Avskiljare och forsterkare for fergsynksignaler
NL7706358A (nl) Hoogspanningsversterker.
FI871665A (fi) Foerfarande foer behandling av smaelt metall och anordning foer utfoerande av foerfarandet.
FI851495L (fi) Foerfarande och anordning foer aostadkommande av en pao foerhand bestaemd viktfoerdelning i tvaerriktningen av en foermatta och/eller matta.
ES511098A0 (es) "un amplificador electrico que comprende medios para eliminar los transitorios del voltaje continuo en su salida".
NL178265C (nl) Antibioticum uit pseudomonas bn-183 en preparaten die dat bevatten.
NL7900567A (nl) Vermogensversterker.
IT8122729A0 (it) Disposizione di amplificatore con distorsione bassissima.
DK312483A (da) Kortikoidholdige praeparater til topisk applikation
DE3672625D1 (de) Kraftverstaerker.
NL7710537A (nl) Insecticide en ovicide preparaten.
DE3688283D1 (de) Mikrowellenleistungsverstaerker.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8100563-9